AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Cartherics Receives $300K G-Rex Grant to Advance Cancer Cell Therapy Manufacturing

Roche Revolutionizes Mass Spectrometry Diagnostics with Launch of cobas® Mass Spec Solution

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Sequencing Service Offerings

NeuroKaire Secures $10M to Transform Precision Medicine in Psychiatry and Neurology

Home
/
update
/
details

UAE: Genetic Testing Required for Citizens Marrying in Abu Dhabi Starting October 1

NextEdge Admin

13 Sep 2024

1 min 49 sec

Starting October 1, citizens in Abu Dhabi will be required to undergo genetic testing as part of the premarital screening program, according to the Department of Health (DoH). This service will be available at 22 primary care centers across Abu Dhabi, Al Dhafra, and Al Ain, with results provided within 14 days. The genetic screening tests for 570 genes linked to over 840 autosomal recessive genetic disorders, helping couples identify if they carry mutations that could potentially affect their future children.

Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at DoH, emphasized that this initiative aims to prevent genetic diseases and enhance early intervention. The process includes diagnostics, personalized genetic counseling, and reproductive medicine solutions for at-risk couples.

Genetic disorders that can be prevented through this program include conditions causing vision and hearing loss, blood clotting disorders, developmental delays, organ dysfunction, hormonal imbalances, and seizures. During the pilot phase, over 800 couples in Abu Dhabi were tested, with 86% achieving genetic compatibility. Only 14% required further intervention, highlighting the program's effectiveness in helping couples make informed family planning decisions.